<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03144349</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A01830-51</org_study_id>
    <nct_id>NCT03144349</nct_id>
  </id_info>
  <brief_title>Diagnosis Accuracy of Hemoconcentration to Detect Hypovolemia During CRRT</brief_title>
  <official_title>Is Variation of Plasmatic Protein Concentration During Continuous Renal Replacement Therapy Predictive of Hypovolemia in Intensive Care Unit?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Louis Pradel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Louis Pradel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to analyze if blood protein concentration variation during continuous
      renal replacement therapy (CRRT) with fluid removal can predict a decrease of 15 % of cardiac
      index in intensive care unit (ICU) patients. Blood protein concentration, clinical data
      describing hemodynamic status (providing data from Pulsion medical system PiCCO2 ®
      monitoring), including preload dependency evaluation with passive leg raising, are collected
      at different times: before initiation of fluid removal, and after the first episode of
      hypotension or one hour after initiation of fluid removal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to analyze if blood protein concentration variation during continuous
      renal replacement therapy (CRRT) with fluid removal can predict a decrease of 15 % of cardiac
      index in intensive care unit (ICU) patients. Blood protein concentration, clinical data
      describing hemodynamic status (providing data from Pulsion medical system PiCCO2 ®
      monitoring), including preload dependency evaluation with passive leg raising, are collected
      at different times: before initiation of fluid removal, and after the first episode of
      hypotension or one hour after initiation of fluid removal.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>plasmatic protein concentration variation</measure>
    <time_frame>1 hour</time_frame>
    <description>Two sample of plasmatic protein before and after a fluid removal will be performed. The variation of the protein concentration (computed as the difference between final and baseline value divided by the baseline value expressed in %) will be the index test to diagnose a decrease of cardiac output of more than 15 % due to the fluid removal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasmatic protein concentration in patient with preload dependency before fluid removal</measure>
    <time_frame>1 hour</time_frame>
    <description>hemoconcentration will be evaluated in the subgroup of preload dependent patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central venous pressure (CVP)</measure>
    <time_frame>1 hour</time_frame>
    <description>CVP will be tested to evaluate the diagnostic ability to diagnose a reduction of cardiac output due the fluid removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global end diastolic volume (GEDV)</measure>
    <time_frame>1 hour</time_frame>
    <description>GEDV, calculated with transpulmonary thermodilution will be tested to evaluate the diagnostic ability to diagnose a reduction of cardiac output due the fluid removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extravascular lung water (EVLW)</measure>
    <time_frame>1 hour</time_frame>
    <description>EVLW, calculated with transpulmonary thermodilution will be tested to evaluate the diagnostic ability to diagnose a reduction of cardiac output due the fluid removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemoconcentration evaluated with hemoglobin variation</measure>
    <time_frame>1 hour</time_frame>
    <description>hemoconcentration evaluated with hemoglobin variation will be tested to evaluate the diagnostic ability to diagnose a reduction of cardiac output due the fluid removal</description>
  </secondary_outcome>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Continuous Renal Replacement Therapy</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Hypovolemia</condition>
  <condition>Fluid Overload</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Ionogram Protidemia Hemogram
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have PiCCO2 ® monitoring and continuous renal replacement therapy with a
        prescription of fluid removal in intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  up to 18 years old

          -  continuous renal replacement therapy

          -  Suspicion of fluid overload

          -  Prescription of fluid removal by the intensivist

          -  PICCO2 monitoring

        Exclusion Criteria:

          -  pregnancy

          -  intra abdominal hypertension

          -  Moribund patient

          -  Abdominal hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Fellahi, M.D.,Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hopital Louis Pradel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthias Jacquet-Lagèze, M.D., M.Sc.</last_name>
    <phone>+33 6 89 99 59</phone>
    <email>matthias.jl@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Luc Fellahi, M.D.,Ph.D.</last_name>
    <phone>+334 72 11 89 42</phone>
    <email>jean-luc.fellahi@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Cardiologique Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <state>Rhône Alpes</state>
        <zip>69350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Jacquet-Lagrèze, M.D., M.Sc.</last_name>
      <phone>+33 6 89 10 99 59</phone>
      <email>matthias.jl@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Luc Fellahi, M.D.,Ph.D.</last_name>
      <phone>+33 4 72 11 89 42</phone>
      <email>jean-luc.fellahi@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Matthias Jacquet-Lagreze</name>
      <address>
        <city>Lyon</city>
        <state>Rhône</state>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthias Jacquet-Lagreze, MD</last_name>
    </contact>
    <investigator>
      <last_name>Matthias MD Jacquet-Lagreze, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf</url>
    <description>KDIGO guidelines 2012</description>
  </link>
  <reference>
    <citation>Lamia B, Ochagavia A, Monnet X, Chemla D, Richard C, Teboul JL. Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med. 2007 Jul;33(7):1125-1132. doi: 10.1007/s00134-007-0646-7. Epub 2007 May 17.</citation>
    <PMID>17508199</PMID>
  </reference>
  <reference>
    <citation>Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med. 2016 Dec;42(12):1935-1947. doi: 10.1007/s00134-015-4134-1. Epub 2016 Jan 29. Review.</citation>
    <PMID>26825952</PMID>
  </reference>
  <reference>
    <citation>Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, Anguel N, Richard C, Teboul JL. The passive leg raising test to guide fluid removal in critically ill patients. Ann Intensive Care. 2016 Dec;6(1):46. doi: 10.1186/s13613-016-0149-1. Epub 2016 May 20.</citation>
    <PMID>27207178</PMID>
  </reference>
  <reference>
    <citation>Bitker L, Bayle F, Yonis H, Gobert F, Leray V, Taponnier R, Debord S, Stoian-Cividjian A, Guérin C, Richard JC. Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care. 2016 Feb 23;20:44. doi: 10.1186/s13054-016-1227-3.</citation>
    <PMID>26907782</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>August 20, 2017</last_update_submitted>
  <last_update_submitted_qc>August 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital Louis Pradel</investigator_affiliation>
    <investigator_full_name>Matthias Jacquet-Lagrèze</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

